BioLine RX News

News

Ticker

BLRX.TA

ISIN

IL0011015182

Pendapatan Keuntungan PER P/S EBIT Dividen Pembelian Insider Saham Kapitalisasi Pasar Utang Utang Modal sendiri AAQS Karyawan ROE ROA ROCE News Dokumen

BioLine RX Berita Eulerpool

BioLine RX Berita Saham

BioLine RX diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini BioLine RX kami rangkum di sini.

20 Maret ·
Benzinga
Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings
26 Februari ·
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
23 Februari ·
Benzinga
Arbitrator Issues Final Award To BioLineRx, Denies All Claims By Biokine Therapeutics; Biokine To Pay Expenses And Legal Fees
29 November ·
Yahoo
BioLine Rx Ltd (BLRX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
25 November ·
Yahoo
BLRX: Stem Cell Mobilization Presentation at ASH
24 November ·
Yahoo
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
24 November ·
SeekingAlpha
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
18 November ·
Yahoo
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
17 November ·
Yahoo
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
30 September ·
Yahoo
BLRX: A Venture into GBM

BioLine RX Siaran Pers Saham

BioLine RX secara rutin mempublikasikan pengumuman yang relevan bagi investor pada situs web perusahaan.

BioLine RX News 2026

Halaman ini berisi semua berita terkini, analisis dan siaran pers untuk saham BioLine RX (BLRX.TA, ISIN: IL0011015182). Ini mencakup berita Eulerpool, analisis perusahaan dan siaran pers resmi. Data diperbarui secara teratur untuk memberikan investor gambaran lengkap tentang perkembangan terbaru di BioLine RX.

BioLine RX Saham

BioLine RX BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe.